##fileformat=VCFv4.1
##source=VarSeqV2.5.0
##fileDate=20230918
##INFO=<ID=Type,Number=1,Type=String,Description="Type of CNV event (either Gain, Loss, or CN LoH)">
##INFO=<ID=Targets,Number=1,Type=Integer,Description="Number of targets in this event">
##INFO=<ID=Samples2,Number=1,Type=Integer,Description="Number of samples that share this event">
##INFO=<ID=Span,Number=1,Type=Integer,Description="Size of this event">
##INFO=<ID=GeneNames,Number=.,Type=String,Description="The set of unique gene names seen in all overlapping transcripts">
##INFO=<ID=GeneIDs,Number=.,Type=String,Description="The set of Entrez gene identifiers for all overlapping transcripts">
##INFO=<ID=Aliases,Number=.,Type=String,Description="Previous names for the set of genes">
##INFO=<ID=Genes,Number=1,Type=Integer,Description="The number of genes overlapping this region.">
##INFO=<ID=TranscriptNameClinicallyRelevant,Number=.,Type=String,Description="The transcript determined to be clinically relevant among those found for the variant's interaction with the gene. If the variant affects multiple genes, one transcript from each gene is selected to be clinically relevant. The clinically relevant transcript is the transcript with the longest coding sequence among the transcripts with an LRG annotation. If a gene has no transcripts that are annotated with an LRG ID, the transcript with the longest coding sequence is used. For more information on how transcripts are chosen see our <a href='http://blog.goldenhelix.com/ajesaitis/whats-in-a-name-the-intricacies-of-identifying-variants/'>blog post on the topic</a>.">
##INFO=<ID=OverlappingExonsClinicallyRelevant,Number=.,Type=String,Description="Which exons of the transcript overlapping this region, or 'All' if they all overlap. Exon numbers are always numbered from the 5' UTR to the 3' UTR.">
##INFO=<ID=HGVSg,Number=1,Type=String,Description="The associated HGVS notation using the genomic reference sequence.">
##INFO=<ID=HGVScClinicallyRelevant,Number=.,Type=String,Description="The associated HGVS coding DNA notation with the clinically relevant transcript(s).">
##INFO=<ID=HGVSpClinicallyRelevant,Number=.,Type=String,Description="The associated HGVS protein change notation with the clinically relevant transcript(s).">
##INFO=<ID=ISCNCytobandNotation,Number=1,Type=String,Description="ISCN notation describing the overlapping cytobands.">
##INFO=<ID=SequenceOntologyClinicallyRelevant,Number=1,Type=String,Description="The sequence ontology associated with the clinically relevant transcript(s).">
##INFO=<ID=RegionClinicallyRelevant,Number=1,Type=String,Description="The region in which the variant is located. When a variant overlaps multiple regions, the region with the highest precedence is given. The order of precedence is defined as (from highest to lowest): exon, utr5, utr3, intron, intergenic.">
##INFO=<ID=Region,Number=.,Type=String,Description="The genomic position of the region.">
##INFO=<ID=Span2,Number=.,Type=Integer,Description="The size of the region (Stop-Stop).">
##INFO=<ID=OverlapType,Number=1,Type=String,Description="Specifies the way in which the CNV overlaps the region. Either \"Contains Region\", \"Within Region\", \"Identical\", or \"Partial Overlap\".">
##INFO=<ID=Name,Number=.,Type=String,Description="DGV Gene Name">
##INFO=<ID=Frequency,Number=.,Type=Float,Description="Samples Count / Num. of Unique Samples">
##INFO=<ID=Type2,Number=1,Type=String,Description="Gain or Loss">
##INFO=<ID=Region2,Number=.,Type=String,Description="The genomic position of the region.">
##INFO=<ID=Span3,Number=.,Type=Integer,Description="The size of the region (Stop-Stop).">
##INFO=<ID=OverlapType2,Number=1,Type=String,Description="Specifies the way in which the CNV overlaps the region. Either \"Contains Region\", \"Within Region\", \"Identical\", or \"Partial Overlap\".">
##INFO=<ID=Type3,Number=1,Type=String,Description="">
##INFO=<ID=Frequency2,Number=.,Type=Float,Description="">
##INFO=<ID=DeletionFrequency,Number=.,Type=Float,Description="">
##INFO=<ID=DuplicationFrequency,Number=.,Type=Float,Description="">
##FORMAT=<ID=CNVState,Number=1,Type=String,Description="State of the CNV event for each sample">
##FORMAT=<ID=AvgTargetMeanDepth,Number=1,Type=Float,Description="Average mean depth of the targets in this event as reported by Coverage Statistics">
##FORMAT=<ID=AvgZScore,Number=1,Type=Float,Description="Average Z-score of the targets in this event">
##FORMAT=<ID=AvgRatio,Number=1,Type=Float,Description="Average ratio of the targets in this event">
##FORMAT=<ID=pvalue,Number=1,Type=Float,Description="Probability that z-scores at least as extreme as those in the event would occur by chance in a normal region.">
##FORMAT=<ID=GeneList,Number=.,Type=String,Description="The genes that the cnv overlaps">
##FORMAT=<ID=CriticalGeneList,Number=.,Type=String,Description="The critical genes that the cnvs overlaps, these genes have established evidence for HI/TS. HI/TS maybe come from genes and regions in clingen or from the internal catalog of gene evaluations.">
##FORMAT=<ID=ScoredGene,Number=.,Type=String,Description="The gene with the maximum score for the gene specific criteria from the critical gene list. This gene has the strongest known effect.">
##FORMAT=<ID=ScoredGeneTranscript,Number=.,Type=String,Description="The transcript for the gene that was scored">
##FORMAT=<ID=Classification,Number=1,Type=String,Description="Classification of the score, this catagorizes the score to it pathogenicity based on the thresholds of Benign: score <= -1, Likely Benign: -1 < score <= -0.9, VUS: -0.9 < score < 0.9, Likely Pathogenic: 0.9 <= score < 1, Pathogenic: score <= 1.">
##FORMAT=<ID=Criteria,Number=.,Type=String,Description="The list of all of the criteria that were applied to reach the 'Total Score' and as a result the 'Classification'.">
##INFO=<ID=END,Number=1,Type=Integer,Description="">
##FORMAT=<ID=GT,Number=1,Type=String,Description="">
##FORMAT=<ID=CN,Number=1,Type=Integer,Description="">
#CHROM	POS	ID	REF	ALT	QUAL	FILTER	INFO	FORMAT	H144-301222-ROCHE_S92_R
1	1450662	.	N	<DEL>	.	.	Type=Loss;Targets=25;Samples2=1;Span=37254;GeneNames=ATAD3B,ATAD3C;GeneIDs=219293,83858;Genes=2;TranscriptNameClinicallyRelevant=NM_031921.6,NM_001039211.3;OverlappingExonsClinicallyRelevant=1-12,All;HGVSg=NC_000001.11:g.1450662_1487915del;HGVScClinicallyRelevant=NM_031921.6:c.1_1266+1del,.;HGVSpClinicallyRelevant=.,.;ISCNCytobandNotation=del(1)p36.33;SequenceOntologyClinicallyRelevant=transcript_ablation,.;RegionClinicallyRelevant=exon,.;Region=1:1417151-1518210,1:1452075-1508336,1:1464845-1473727;Span2=101060,56262,8883;OverlapType=Within Region,Partial Overlap,Contains Region;Name=gssvL100,gssvL107,gssvL125;Frequency=0.008,0.0105,0.0133;Type2=Loss,Loss,Loss;Region2=1:1464961-1473537;Span3=8577;OverlapType2=Contains Region;Type3=Deletion;Frequency2=0.0190275;DeletionFrequency=0.0190275;DuplicationFrequency=0;END=1487915	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:63.1432:-2.79958:0.546798:5.09479910079628e-30:ATAD3B,ATAD3C::ATAD3C:NM_001039211.3:VUS:2B0WhiletheCNVoverlapstheATAD3CgeneitisunclearifthisisthecausativegeneforhaploinsufficientregionISCA-37434inClinGenDosageSensitivity.,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:1
1	13321683	.	N	<DEL>	.	.	Type=Loss;Targets=5;Samples2=15;Span=23701;GeneNames=PRAMEF14,PRAMEF15;GeneIDs=653619,729528;Genes=2;TranscriptNameClinicallyRelevant=NM_001024661.2,NM_001098376.3;OverlappingExonsClinicallyRelevant=2-4,4;HGVSg=NC_000001.11:g.13321683_13345383del;HGVScClinicallyRelevant=.,NM_001098376.3:c.876-20_1437del;HGVSpClinicallyRelevant=.,.;ISCNCytobandNotation=del(1)p36.21;SequenceOntologyClinicallyRelevant=.,transcript_ablation;RegionClinicallyRelevant=.,exon;END=13345383	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:117.215:-3.10998:0.611529:1.67479859736863e-08:PRAMEF14,PRAMEF15::.:.:Benign:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps2proteincodinggenes,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:1
1	31671578	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=1;Span=120;GeneNames=COL16A1;GeneIDs=1307;Aliases=447AA,FP1572;Genes=1;TranscriptNameClinicallyRelevant=NM_001856.4;OverlappingExonsClinicallyRelevant=48;HGVSg=NC_000001.11:g.31671578_31671697dup;HGVScClinicallyRelevant=NM_001856.4:c.3106-38_3150+37dup;HGVSpClinicallyRelevant=NP_001847.3:p.M1040_G1054dup;ISCNCytobandNotation=dup(1)p35.2;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;END=31671697	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:146.917:4.72327:1.73908:0.000144224951521996:COL16A1:COL16A1:COL16A1:NM_001856.4:VUS:3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
1	43591821	.	N	<DUP>	.	.	Type=Gain;Targets=3;Samples2=1;Span=6241;GeneNames=PTPRF;GeneIDs=5792;Aliases=BNAH2,LAR;Genes=1;TranscriptNameClinicallyRelevant=NM_002840.5;OverlappingExonsClinicallyRelevant=10-12;HGVSg=NC_000001.11:g.43591821_43598061dup;HGVScClinicallyRelevant=NM_002840.5:c.1541_2119+8dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(1)p34.2;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=43598061	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:130.531:2.71149:1.37305:0.000161076999167573:PTPRF::PTPRF:NM_002840.5:VUS:2L0ThiscnvpartiallyoverlapsthePTPRFgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
1	102912126	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=2;Span=120;GeneNames=COL11A1;GeneIDs=1301;Aliases=CO11A1,COLL6,DFNA37,STL2;Genes=1;TranscriptNameClinicallyRelevant=NM_001854.4;OverlappingExonsClinicallyRelevant=54;HGVSg=NC_000001.11:g.102912126_102912245dup;HGVScClinicallyRelevant=NM_001854.4:c.4033-33_4086+33dup;HGVSpClinicallyRelevant=NP_001845.3:p.P1349_G1366dup;ISCNCytobandNotation=dup(1)p21.1;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;END=102912245	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:77.5667:4.95847:1.78789:6.52974930831426e-05:COL11A1::COL11A1:NM_001854.4:VUS:2L0ThiscnvpartiallyoverlapstheCOL11A1genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
1	149003611	.	N	<DUP>	.	.	Type=Gain;Targets=3;Samples2=2;Span=1866;GeneNames=PDE4DIP;GeneIDs=9659;Aliases=CMYA2,MMGL;Genes=1;TranscriptNameClinicallyRelevant=NM_001395426.1;OverlappingExonsClinicallyRelevant=29-30;HGVSg=NC_000001.11:g.149003611_149005476dup;HGVScClinicallyRelevant=NM_001395426.1:c.3965_4613+39dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(1)q21.2;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=149005476	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:121.469:2.52848:1.44406:0.000440896031820335:PDE4DIP::PDE4DIP:NM_001395426.1:Benign:2L0ThiscnvpartiallyoverlapsthePDE4DIPgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
1	156971697	.	N	<DUP>	.	.	Type=Gain;Targets=2;Samples2=1;Span=5381;GeneNames=ARHGEF11;GeneIDs=9826;Aliases=GTRAP48,PDZ-RHOGEF;Genes=1;TranscriptNameClinicallyRelevant=NM_198236.3;OverlappingExonsClinicallyRelevant=7-8;HGVSg=NC_000001.11:g.156971697_156977077dup;HGVScClinicallyRelevant=NM_198236.3:c.511-23_702dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(1)q23.1;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=156977077	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:135.979:3.47644:1.46999:7.64231000629802e-05:ARHGEF11::ARHGEF11:NM_198236.3:VUS:2L0ThiscnvpartiallyoverlapstheARHGEF11genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
1	161517895	.	N	<DEL>	.	.	Type=Loss;Targets=10;Samples2=1;Span=73513;GeneNames=FCGR2A,FCGR2C,FCGR3A,HSPA6,TRG-GCC2-1,TRG-TCC2-6,TRL-CAG1-6,TRN-GTT1-1;GeneIDs=2212,100189380,3310,100189018,100189011,100189126,2214,9103;Aliases=CD32,CD32A,CDw32,FCG2,FCGR2,FCGR2A1,FcGR,FcgammaRIIa,IGFR2;Genes=8;TranscriptNameClinicallyRelevant=NM_001136219.3,NR_047648.1,NM_000569.8,NM_002155.5,TRG-GCC2-1,TRG-TCC2-6,TRL-CAG1-6,TRN-GTT1-1;OverlappingExonsClinicallyRelevant=7,1-4,All,All,All,All,All,All;HGVSg=NC_000001.11:g.161517895_161591407del;HGVScClinicallyRelevant=NM_001136219.3:c.781-80_954del,.,.,.,.,.,.,.;HGVSpClinicallyRelevant=.,.,.,.,.,.,.,.;ISCNCytobandNotation=del(1)q23.3;SequenceOntologyClinicallyRelevant=transcript_ablation,.,.,.,.,.,.,.;RegionClinicallyRelevant=exon,.,.,.,.,.,.,.;Region=1:161507558-161682500,1:161512733-161623692,1:161518654-161572474,1:161548423-161671187;Span2=174943,110960,53821,122765;OverlapType=Within Region,Within Region,Contains Region,Partial Overlap;Name=gssvL5771,gssvL5774,gssvL5775,gssvL5772;Frequency=0.0066,0.0309,0.007,0.0192;Type2=Loss,Loss,Loss,Loss;Region2=1:161514315-161595972,1:161516542-161676747,1:161561481-161642825;Span3=81658,160206,81345;OverlapType2=Within Region,Within Region,Partial Overlap;Type3=Deletion,Deletion,Deletion;Frequency2=0.00739958,0.325,0.0539112;DeletionFrequency=0.00739958,0.325,0.0539112;DuplicationFrequency=0,0,0;END=161591407	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:72.7334:-2.41112:0.547923:5.83766693899013e-10:FCGR2A,FCGR2C,FCGR3A,HSPA6,TRG-GCC2-1,TRG-TCC2-6,TRL-CAG1-6,TRN-GTT1-1::FCGR3A:NM_000569.8:Benign:2G0TheCNVisoverlapsthehaplobenignregionISCA-46333inClinGenDosageSensitivitybutincludesadditionalmaterial.,3A0Thiscnvoverlaps3proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:1
2	231344975	.	N	<DUP>	.	.	Type=Gain;Targets=5;Samples2=2;Span=26609;GeneNames=ARMC9,MIR4777;GeneIDs=80210,100616317;Aliases=ARM,JBTS30,KU-MEL-1,NS21;Genes=2;TranscriptNameClinicallyRelevant=NM_025139.6,NR_039937.1;OverlappingExonsClinicallyRelevant=21,All;HGVSg=NC_000002.12:g.231344975_231371583dup;HGVScClinicallyRelevant=NM_025139.6:c.1879_1998dup,.;HGVSpClinicallyRelevant=.,.;ISCNCytobandNotation=dup(2)q37.1;SequenceOntologyClinicallyRelevant=3_prime_UTR_variant,.;RegionClinicallyRelevant=UTR3,.;END=231371583	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:125.61:3.24677:1.36337:4.6965060893679e-09:ARMC9,MIR4777::ARMC9:NM_025139.6:VUS:2L0ThiscnvpartiallyoverlapstheARMC9genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
5	134758887	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=2;Span=120;GeneNames=DDX46;GeneIDs=9879;Aliases=PRPF5,Prp5;Genes=1;TranscriptNameClinicallyRelevant=NM_001300860.2;OverlappingExonsClinicallyRelevant=1;HGVSg=NC_000005.10:g.134758887_134759006dup;HGVScClinicallyRelevant=NM_001300860.2:c.1_17+51dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(5)q31.1;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=134759006	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:149.267:5.08741:1.69478:4.16734781527643e-05:DDX46::DDX46:NM_001300860.2:VUS:2L0ThiscnvpartiallyoverlapstheDDX46genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
5	176108580	.	N	<DEL>	.	.	Type=Loss;Targets=3;Samples2=1;Span=5478;GeneNames=FAM153B;GeneIDs=202134;Genes=1;TranscriptNameClinicallyRelevant=NM_001265615.2;OverlappingExonsClinicallyRelevant=16-20;HGVSg=NC_000005.10:g.176108580_176114057del;HGVScClinicallyRelevant=NM_001265615.2:c.632-25_933del;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=del(5)q35.2;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=176114057	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:25.9449:-2.59046:0.495406:0.000285219553733442:FAM153B::.:.:VUS:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps1proteincodinggenes:1
6	32038324	.	N	<DUP>	.	.	Type=Gain;Targets=7;Samples2=1;Span=3136;GeneNames=CYP21A2,TNXB;GeneIDs=1589,7148;Aliases=CA21H,CAH1,CYP21,CYP21B,P450c21B;Genes=2;TranscriptNameClinicallyRelevant=NM_000500.9,NM_019105.8;OverlappingExonsClinicallyRelevant=All,44;HGVSg=NC_000006.12:g.32038324_32041459dup;HGVScClinicallyRelevant=.,NM_019105.8:c.12628-9_12729dup;HGVSpClinicallyRelevant=.,.;ISCNCytobandNotation=dup(6)p21.33;SequenceOntologyClinicallyRelevant=.,transcript_ablation;RegionClinicallyRelevant=.,exon;END=32041459	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:166.106:2.86183:1.45053:1.0100061935472e-09:CYP21A2,TNXB::TNXB:NM_019105.8:Benign:2L0ThiscnvpartiallyoverlapstheTNXBgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
7	92084819	.	N	<DUP>	.	.	Type=Gain;Targets=2;Samples2=1;Span=876;GeneNames=AKAP9;GeneIDs=10142;Aliases=AKAP-9,AKAP350,AKAP450,CG-NAP,HYPERION,LQT11,MU-RMS-40.16A,PPP1R45,PRKA9,YOTIAO;Genes=1;TranscriptNameClinicallyRelevant=NM_005751.5;OverlappingExonsClinicallyRelevant=35-36;HGVSg=NC_000007.14:g.92084819_92085694dup;HGVScClinicallyRelevant=NM_005751.5:c.8711_9024+8dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(7)q21.2;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=92085694	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:102.5:3.41063:1.55108:0.000104722819533767:AKAP9::AKAP9:NM_005751.5:VUS:2L0ThiscnvpartiallyoverlapstheAKAP9genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
7	142065578	.	N	<DEL>	.	.	Type=Loss;Targets=15;Samples2=2;Span=19064;GeneNames=MGAM;GeneIDs=8972;Aliases=MG;Genes=1;TranscriptNameClinicallyRelevant=NM_004668.3;OverlappingExonsClinicallyRelevant=.;HGVSg=NC_000007.14:g.142065578_142084641del;HGVScClinicallyRelevant=NM_004668.3:c.4618+110_4619-9979del;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=del(7)q34;SequenceOntologyClinicallyRelevant=intron_variant;RegionClinicallyRelevant=intron;Region=7:142041807-142099348,7:142050223-142084684,7:142060398-142099360,7:142065905-142086994;Span2=57542,34462,38963,21090;OverlapType=Within Region,Within Region,Within Region,Partial Overlap;Name=gssvL119327,gssvL119329,gssvL119328,gssvL119332;Frequency=0.0441,0.0027,0.0409,0.0073;Type2=Loss,Loss,Loss,Loss;Region2=7:142060932-142093800,7:142065727-142078454,7:142078905-142086749;Span3=32869,12728,7845;OverlapType2=Within Region,Contains Region,Partial Overlap;Type3=Deletion,Deletion,Deletion;Frequency2=0.279598,0.00118343,0.00118343;DeletionFrequency=0.279598,0.00118343,0.00118343;DuplicationFrequency=0,0,0;END=142084641	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:70.0786:-2.25986:0.574277:1.10580009331399e-12:MGAM::MGAM:NM_004668.3:Benign:2F-1ThecnvdoesnotincludeanyproteincodinggenesoutsideoftheknownhaplobenignregionISCA-46375inClinGenDosageSensitivity.,1B-0.6TheCNVdoesnotoverlapthecodingregionofanygenes:1
8	51408057	.	N	<DEL>	.	.	Type=Loss;Targets=1;Samples2=2;Span=1514;GeneNames=PXDNL;GeneIDs=137902;Aliases=PMR1,VPO2;Genes=1;TranscriptNameClinicallyRelevant=NM_144651.5;OverlappingExonsClinicallyRelevant=17;HGVSg=NC_000008.11:g.51408057_51409570del;HGVScClinicallyRelevant=NM_144651.5:c.2063-9_3557+10del;HGVSpClinicallyRelevant=NP_653252.4:p.E688Gfs*20;ISCNCytobandNotation=del(8)q11.22;SequenceOntologyClinicallyRelevant=frameshift_variant;RegionClinicallyRelevant=exon;END=51409570	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:65.0528:-8.23854:0.55486:2.43074988329579e-11:PXDNL::.:.:VUS:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps1proteincodinggenes:1
9	129063220	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=1;Span=120;GeneNames=MIGA2;GeneIDs=84895;Aliases=C9orf54,FAM73B;Genes=1;TranscriptNameClinicallyRelevant=NM_001329990.2;OverlappingExonsClinicallyRelevant=10;HGVSg=NC_000009.12:g.129063220_129063339dup;HGVScClinicallyRelevant=NM_001329990.2:c.1011-24_1083+23dup;HGVSpClinicallyRelevant=NP_001316919.1:p.G362Dfs*9;ISCNCytobandNotation=dup(9)q34.11;SequenceOntologyClinicallyRelevant=frameshift_variant;RegionClinicallyRelevant=exon;END=129063339	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:140.7:4.63102:1.62399:0.000194957498827967:MIGA2::MIGA2:NM_001329990.2:VUS:2L0ThiscnvpartiallyoverlapstheMIGA2genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
10	46038959	.	N	<DUP>	.	.	Type=Gain;Targets=35;Samples2=1;Span=546828;GeneNames=AGAP7P,AGAP14P,ANTXRL,ANTXRLP1,ANXA8L1,FAM25BP,GPRIN2,HNRNPA1P33,LINC00842,LOC105378577,MSMB,NPY4R,SYT15,SYT15-AS1;GeneIDs=4477,653268,100996567,105378577,195977,653259,100132929,728113,643650,728643,5540,9721,83849,101927699;Aliases=HPC13,IGBF,MSP,MSPB,PN44,PRPS,PSP,PSP-94,PSP57,PSP94;Genes=14;TranscriptNameClinicallyRelevant=NR_126580.1,NR_165820.1,NM_001278688.3,NR_103828.1,NM_001098845.3,NR_104039.1,NM_001385282.1,NR_003277.2,NR_033957.2,NR_160731.1,NM_002443.4,NM_005972.6,NM_031912.5,NR_155739.1;OverlappingExonsClinicallyRelevant=All,All,All,All,All,All,All,All,All,All,1-3,All,1-7,3;HGVSg=NC_000010.11:g.46038959_46585786dup;HGVScClinicallyRelevant=.,.,.,.,.,.,.,.,.,.,NM_002443.4:c.1_215+7dup,.,NM_031912.5:c.1_1123+9dup,.;HGVSpClinicallyRelevant=.,.,.,.,.,.,.,.,.,.,.,.,.,.;ISCNCytobandNotation=dup(10)q11.22;SequenceOntologyClinicallyRelevant=.,.,.,.,.,.,.,.,.,.,transcript_ablation,.,transcript_ablation,.;RegionClinicallyRelevant=.,.,.,.,.,.,.,.,.,.,exon,.,exon,.;Region=10:45681633-47114104,10:45751907-47815598,10:46146408-46333191,10:46157934-46393598,10:46166132-46281567;Span2=1432472,2063692,186784,235665,115436;OverlapType=Within Region,Within Region,Contains Region,Contains Region,Contains Region;Name=gssvG4473,gssvG4472,gssvG4677,gssvG4491,gssvG4499;Frequency=0.0021,0.014,0.0015,0.0073,0.0065;Type2=Gain,Gain,Gain,Gain,Gain;Region2=10:46157967-46333769;Span3=175803;OverlapType2=Contains Region;Type3=Duplication;Frequency2=0.953333;DeletionFrequency=0;DuplicationFrequency=0.953333;END=46585786	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:156.438:1.92809:1.31478:3.66090718429594e-20:AGAP7P,AGAP14P,ANTXRL,ANTXRLP1,ANXA8L1,FAM25BP,GPRIN2,HNRNPA1P33,LINC00842,LOC105378577,MSMB,NPY4R,SYT15,SYT15-AS1::ANTXRL:NM_001278688.3:Benign:2G0TheCNVisoverlapsthetriplobenignregionISCA-46639inClinGenDosageSensitivitybutincludesadditionalmaterial.,3A0Thiscnvoverlaps6proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
10	86970172	.	N	<DUP>	.	.	Type=Gain;Targets=2;Samples2=7;Span=418;GeneNames=ADIRF,ADIRF-AS1,AGAP11;GeneIDs=100133190,10974,119385;Genes=3;TranscriptNameClinicallyRelevant=NM_006829.3,NR_170182.1,NR_171046.1;OverlappingExonsClinicallyRelevant=2-3,1,1;HGVSg=NC_000010.11:g.86970172_86970589dup;HGVScClinicallyRelevant=NM_006829.3:c.62-28_231dup,.,.;HGVSpClinicallyRelevant=.,.,.;ISCNCytobandNotation=dup(10)q23.2;SequenceOntologyClinicallyRelevant=transcript_ablation,.,.;RegionClinicallyRelevant=exon,.,.;END=86970589	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:106.025:3.08314:1.50547:0.000463516280074595:ADIRF,ADIRF-AS1,AGAP11::ADIRF:NM_006829.3:VUS:2L0ThiscnvpartiallyoverlapstheADIRFgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
12	30983047	.	N	<DUP>	.	.	Type=Gain;Targets=4;Samples2=1;Span=95500;GeneNames=DDX11,DDX11-AS1,TSPAN11;GeneIDs=441631,100506660,1663;Aliases=VSSW1971;Genes=3;TranscriptNameClinicallyRelevant=NM_030653.4,NR_038927.2,NM_001370302.1;OverlappingExonsClinicallyRelevant=1-2,All,7-8;HGVSg=NC_000012.12:g.30983047_31078546dup;HGVScClinicallyRelevant=NM_030653.4:c.1_144+9dup,.,NM_001370302.1:c.616-17_762dup;HGVSpClinicallyRelevant=.,.,.;ISCNCytobandNotation=dup(12)p11.21;SequenceOntologyClinicallyRelevant=transcript_ablation,.,transcript_ablation;RegionClinicallyRelevant=exon,.,exon;Region=12:30802222-31152256;Span2=350035;OverlapType=Within Region;Name=gssvG7669;Frequency=0.0002;Type2=Gain;END=31078546	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:85.4148:2.28871:1.30573:0.000238708748562475:DDX11,DDX11-AS1,TSPAN11::DDX11:NM_030653.4:VUS:2L0ThiscnvpartiallyoverlapstheDDX11genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
12	50181911	.	N	<DEL>	.	.	Type=Loss;Targets=2;Samples2=1;Span=10658;GeneNames=LIMA1;GeneIDs=51474;Aliases=EPLIN,LDLCQ8,SREBP3;Genes=1;TranscriptNameClinicallyRelevant=NM_016357.5;OverlappingExonsClinicallyRelevant=9-10;HGVSg=NC_000012.12:g.50181911_50192568del;HGVScClinicallyRelevant=NM_016357.5:c.1031-7_1267del;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=del(12)q13.12;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=50192568	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:45.2042:-3.74602:0.516604:1.80490109143792e-05:LIMA1::.:.:VUS:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps1proteincodinggenes:1
12	52451665	.	N	<DEL>	.	.	Type=Loss;Targets=24;Samples2=2;Span=41005;GeneNames=KRT6A,KRT6B,KRT6C;GeneIDs=3854,286887,3853;Aliases=CK-6B,CK6B,K6B,KRTL1,PC2,PC4;Genes=3;TranscriptNameClinicallyRelevant=NM_005554.4,NM_005555.4,NM_173086.5;OverlappingExonsClinicallyRelevant=All,1,All;HGVSg=NC_000012.12:g.52451665_52492669del;HGVScClinicallyRelevant=NM_005554.4:c.520_1695del,NM_005555.4:c.1_414del,.;HGVSpClinicallyRelevant=NP_005545.1:p.F174Sext?,NP_005546.2:p.M1_V138del,.;ISCNCytobandNotation=del(12)q13.13;SequenceOntologyClinicallyRelevant=stop_lost,initiator_codon_variant,.;RegionClinicallyRelevant=exon,exon,.;Region=12:52450680-52492330,12:52469059-52491424;Span2=41651,22366;OverlapType=Partial Overlap,Contains Region;Name=gssvL24981,gssvL24983;Frequency=0.0004,0.0148;Type2=Loss,Loss;Region2=12:52449143-52492330,12:52450456-52488001,12:52452110-52470536,12:52452169-52470814,12:52470457-52486920,12:52470559-52489574;Span3=43188,37546,18427,18646,16464,19016;OverlapType2=Partial Overlap,Partial Overlap,Contains Region,Contains Region,Contains Region,Contains Region;Type3=Deletion,Deletion,Deletion,Deletion,Deletion,Deletion;Frequency2=0.000337895,0.0035503,0.00118343,0.00067579,0.000168947,0.000528541;DeletionFrequency=0.000337895,0.0035503,0.00118343,0.00067579,0.000168947,0.000528541;DuplicationFrequency=0,0,0,0,0,0;END=52492669	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:96.5695:-3.60775:0.630285:8.79498618481344e-47:KRT6A,KRT6B,KRT6C::.:.:VUS:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps3proteincodinggenes:1
14	105621898	.	N	<DUP>	.	.	Type=Gain;Targets=3;Samples2=4;Span=4178;Region=14:105614083-105633581;Span2=19499;OverlapType=Within Region;Name=gssvG12125;Frequency=0.0026;Type2=Gain;Region2=14:105615487-105630408;Span3=14922;OverlapType2=Within Region;Type3=Duplication;Frequency2=0.025;DeletionFrequency=0;DuplicationFrequency=0.025;END=105626075	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:416.365:3.1346:1.65515:1.23556480742294e-05:::.:.:Benign:1B-0.6TheCNVdoesnotoverlapanygenes,2D-1ThecnvissmallerthanthetriplobenignregionISCA-37477inClinGenDosageSensitivityanddoesnotinteruptanyprotiencodinggenes,3A0Thiscnvoverlaps0proteincodinggenes:3
15	41568849	.	N	<DUP>	.	.	Type=Gain;Targets=11;Samples2=1;Span=9436;GeneNames=TYRO3;GeneIDs=7301;Aliases=BYK,Dtk,Etk-2,RSE,Rek,Sky,Tif;Genes=1;TranscriptNameClinicallyRelevant=NM_006293.4;OverlappingExonsClinicallyRelevant=9-19;HGVSg=NC_000015.10:g.41568849_41578284dup;HGVScClinicallyRelevant=NM_006293.4:c.1108-29_2673dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(15)q15.1;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=41578284	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:191.128:2.31986:1.24828:5.56518786640166e-10:TYRO3::TYRO3:NM_006293.4:VUS:2L0ThiscnvpartiallyoverlapstheTYRO3genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
15	67821933	.	N	<DUP>	.	.	Type=Gain;Targets=2;Samples2=2;Span=246;END=67822178	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:154.833:3.58835:1.49825:4.41755204261525e-05:::.:.:Benign:1B-0.6TheCNVdoesnotoverlapanygenes,3A0Thiscnvoverlaps0proteincodinggenes,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
16	268766	.	N	<DUP>	.	.	Type=Gain;Targets=2;Samples2=1;Span=248;GeneNames=RGS11;GeneIDs=8786;Aliases=RS11;Genes=1;TranscriptNameClinicallyRelevant=NM_183337.3;OverlappingExonsClinicallyRelevant=17;HGVSg=NC_000016.10:g.268766_269013dup;HGVScClinicallyRelevant=.;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(16)p13.3;SequenceOntologyClinicallyRelevant=.;RegionClinicallyRelevant=.;END=269013	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:143.225:3.21378:1.45011:0.000260179182196931:RGS11::.:.:VUS:1B-0.6TheCNVdoesnotoverlapthecodingregionofanygenes,3A0Thiscnvoverlaps1proteincodinggenes:3
16	22181528	.	N	<DUP>	.	.	Type=Gain;Targets=2;Samples2=1;Span=776;GeneNames=SDR42E2;GeneIDs=100288072;Genes=1;TranscriptNameClinicallyRelevant=NM_001394319.2;OverlappingExonsClinicallyRelevant=9-10;HGVSg=NC_000016.10:g.22181528_22182303dup;HGVScClinicallyRelevant=NM_001394319.2:c.682_876+26dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(16)p12.2;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=22182303	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:117.225:3.31494:1.42796:0.000163981766692006:SDR42E2::SDR42E2:NM_001394319.2:VUS:2L0ThiscnvpartiallyoverlapstheSDR42E2genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
16	69963532	.	N	<DUP>	.	.	Type=Gain;Targets=22;Samples2=2;Span=222458;GeneNames=CLEC18A,CLEC18C,LOC400541,MIR1972-2,PDPR,PDXDC2P-NPIPB14P;GeneIDs=348174,283970,100422922,55066,400541,283971;Aliases=MRCL,MRCL1,MRLP2;Genes=6;TranscriptNameClinicallyRelevant=NM_001370523.4,NM_173619.4,NR_126007.1,NR_036265.1,NM_017990.5,NR_003610.1;OverlappingExonsClinicallyRelevant=12,1-12,All,All,All,All;HGVSg=NC_000016.10:g.69963532_70185989dup;HGVScClinicallyRelevant=NM_001370523.4:c.1304-42_1341dup,NM_173619.4:c.1_1303+13dup,.,.,.,.;HGVSpClinicallyRelevant=.,.,.,.,.,.;ISCNCytobandNotation=dup(16)q22.1;SequenceOntologyClinicallyRelevant=transcript_ablation,transcript_ablation,.,.,.,.;RegionClinicallyRelevant=exon,exon,.,.,.,.;Region=16:69943494-70243716,16:69954471-70164481,16:69972156-70034749,16:70090445-70251178,16:70111451-70179141;Span2=300223,210011,62594,160734,67691;OverlapType=Within Region,Partial Overlap,Contains Region,Partial Overlap,Contains Region;Name=gssvG15173,gssvG15174,gssvG15183,gssvG15176,gssvG15182;Frequency=0.0026,0.0016,0.0167,0.0038,0.0647;Type2=Gain,Gain,Gain,Gain,Gain;Region2=16:70106838-70177676,16:70111452-70162599,16:70117625-70247875;Span3=70839,51148,130251;OverlapType2=Contains Region,Contains Region,Partial Overlap;Type3=Duplication,Duplication,Duplication;Frequency2=0.00523737,0.755556,0.00101369;DeletionFrequency=0,0,0;DuplicationFrequency=0.00523737,0.755556,0.00101369;END=70185989	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:183.655:1.66229:1.30601:3.49209219159074e-10:CLEC18A,CLEC18C,LOC400541,MIR1972-2,PDPR,PDXDC2P-NPIPB14P::PDPR:NM_017990.5:Benign:2G0TheCNVisoverlapsthetriplobenignregionISCA-46493inClinGenDosageSensitivitybutincludesadditionalmaterial.,3A0Thiscnvoverlaps3proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
17	21535290	.	N	<DUP>	.	.	Type=Gain;Targets=4;Samples2=3;Span=168807;GeneNames=KCNJ18,LINC02693;GeneIDs=339263,100134444;Aliases=C17orf51;Genes=2;TranscriptNameClinicallyRelevant=NM_001194958.2,NR_160801.1;OverlappingExonsClinicallyRelevant=All,All;HGVSg=NC_000017.11:g.21535290_21704096dup;HGVScClinicallyRelevant=.,.;HGVSpClinicallyRelevant=.,.;ISCNCytobandNotation=dup(17)p11.2;SequenceOntologyClinicallyRelevant=.,.;RegionClinicallyRelevant=.,.;Region=17:21328740-21633027,17:21408336-21790547,17:21454183-21626320,17:21613734-21663282;Span2=304288,382212,172138,49549;OverlapType=Partial Overlap,Within Region,Partial Overlap,Contains Region;Name=gssvG16158,gssvG16157,gssvG16161,gssvG16175;Frequency=0.0013,0.0006,0.0048,0.0096;Type2=Gain,Gain,Gain,Gain;Region2=17:21440878-21637070,17:21608270-21797952;Span3=196193,189683;OverlapType2=Partial Overlap,Partial Overlap;Type3=Duplication,Duplication;Frequency2=0.00236686,0.00118343;DeletionFrequency=0,0;DuplicationFrequency=0.00236686,0.00118343;END=21704096	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:264.443:5.77581:1.506:9.15299471250233e-21:KCNJ18,LINC02693::.:.:VUS:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps1proteincodinggenes:3
17	41378043	.	N	<DUP>	.	.	Type=Gain;Targets=6;Samples2=9;Span=4419;GeneNames=KRT34;GeneIDs=3885;Aliases=HA4,Ha-4,K34,KRTHA4,hHa4;Genes=1;TranscriptNameClinicallyRelevant=NM_001386014.1;OverlappingExonsClinicallyRelevant=All;HGVSg=NC_000017.11:g.41378043_41382461dup;HGVScClinicallyRelevant=.;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(17)q21.2;SequenceOntologyClinicallyRelevant=.;RegionClinicallyRelevant=.;Region=17:41372895-41391063,17:41375424-41383870,17:41375715-41380422;Span2=18169,8447,4708;OverlapType=Within Region,Within Region,Partial Overlap;Name=gssvG16535,gssvG16538,gssvG16540;Frequency=0.0033,0.0555,0.0225;Type2=Gain,Gain,Gain;Region2=17:41376050-41383330,17:41376050-41383372,17:41376618-41380422,17:41376618-41393899,17:41377781-41384072;Span3=7281,7323,3805,17282,6292;OverlapType2=Within Region,Within Region,Partial Overlap,Within Region,Within Region;Type3=Duplication,Duplication,Duplication,Duplication,Duplication;Frequency2=0.175,0.98,0.000168947,0.000168947,0.043787;DeletionFrequency=0,0,0,0,0;DuplicationFrequency=0.175,0.98,0.000168947,0.000168947,0.043787;END=41382461	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:334.37:3.02167:1.33941:2.35673763715014e-09:KRT34::KRT34:NM_001386014.1:Benign:2D-1ThecnvissmallerthanthetriplobenignregionISCA-46707inClinGenDosageSensitivityanddoesnotinteruptanyprotiencodinggenes,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
17	58511410	.	N	<DUP>	.	.	Type=Gain;Targets=4;Samples2=1;Span=3036;GeneNames=MTMR4;GeneIDs=9110;Aliases=FYVE-DSP2,ZFYVE11;Genes=1;TranscriptNameClinicallyRelevant=NM_001378067.1;OverlappingExonsClinicallyRelevant=1-4;HGVSg=NC_000017.11:g.58511410_58514445dup;HGVScClinicallyRelevant=NM_001378067.1:c.1_335+19dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(17)q22;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=58514445	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:123.398:2.56364:1.38785:3.74189830315207e-05:MTMR4::MTMR4:NM_001378067.1:VUS:2L0ThiscnvpartiallyoverlapstheMTMR4genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
17	64507047	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=2;Span=120;GeneNames=CEP95;GeneIDs=90799;Aliases=CCDC45;Genes=1;TranscriptNameClinicallyRelevant=NM_138363.3;OverlappingExonsClinicallyRelevant=1;HGVSg=NC_000017.11:g.64507047_64507166dup;HGVScClinicallyRelevant=NM_138363.3:c.1_19+50dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(17)q23.3;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=64507166	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:119.325:4.52377:1.68069:0.000274931351399234:CEP95::CEP95:NM_138363.3:VUS:2L0ThiscnvpartiallyoverlapstheCEP95genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
19	11034105	.	N	<DUP>	.	.	Type=Gain;Targets=3;Samples2=3;Span=1042;GeneNames=SMARCA4;GeneIDs=6597;Aliases=BAF190,BAF190A,BRG1,CSS4,MRD16,RTPS2,SNF2,SNF2-beta,SNF2L4,SNF2LB,SWI2,hSNF2b;Genes=1;TranscriptNameClinicallyRelevant=NM_001128849.3;OverlappingExonsClinicallyRelevant=28-29;HGVSg=NC_000019.10:g.11034105_11035146dup;HGVScClinicallyRelevant=NM_001128849.3:c.3874-18_4170+14dup;HGVSpClinicallyRelevant=NP_001122321.1:p.E1292_K1390dup;ISCNCytobandNotation=dup(19)p13.2;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;END=11035146	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:157.622:2.84258:1.44288:7.53576462680362e-05:SMARCA4::SMARCA4:NM_001128849.3:VUS:2L0ThiscnvpartiallyoverlapstheSMARCA4genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
19	19532626	.	N	<DUP>	.	.	Type=Gain;Targets=2;Samples2=1;Span=2523;GeneNames=YJEFN3;GeneIDs=374887;Genes=1;TranscriptNameClinicallyRelevant=NM_198537.4;OverlappingExonsClinicallyRelevant=3-4;HGVSg=NC_000019.10:g.19532626_19535148dup;HGVScClinicallyRelevant=NM_198537.4:c.210-6_429+4dup;HGVSpClinicallyRelevant=NP_940939.2:p.E144Hfs*30;ISCNCytobandNotation=dup(19)p13.11;SequenceOntologyClinicallyRelevant=frameshift_variant;RegionClinicallyRelevant=exon;END=19535148	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:137.262:3.8908:1.45526:9.28339512861367e-06:YJEFN3::YJEFN3:NM_198537.4:VUS:2L0ThiscnvpartiallyoverlapstheYJEFN3genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
19	42855549	.	N	<DEL>	.	.	Type=Loss;Targets=30;Samples2=10;Span=170868;GeneNames=PSG1,PSG6,PSG7,PSG10P,PSG11;GeneIDs=653492,5669,5675,5676,5680;Aliases=PSG10,PSG12;Genes=5;TranscriptNameClinicallyRelevant=NM_001184825.2,NM_001031850.4,NM_002783.3,NR_026824.1,NM_002785.3;OverlappingExonsClinicallyRelevant=All,All,All,1,All;HGVSg=NC_000019.10:g.42855549_43026416del;HGVScClinicallyRelevant=.,.,.,.,.;HGVSpClinicallyRelevant=.,.,.,.,.;ISCNCytobandNotation=del(19)q13.2-q13.31;SequenceOntologyClinicallyRelevant=.,.,.,.,.;RegionClinicallyRelevant=.,.,.,.,.;Region=19:42634891-43060188,19:42721418-42951525,19:42733459-43286626,19:42788811-43044850,19:42838106-42943182,19:42847842-42907051,19:42857733-43193181,19:42878950-43042247,19:42908380-42950466,19:42918190-43344645,19:42951426-43044850;Span2=425298,230108,553168,256040,105077,59210,335449,163298,42087,426456,93425;OverlapType=Within Region,Partial Overlap,Within Region,Within Region,Partial Overlap,Partial Overlap,Partial Overlap,Partial Overlap,Contains Region,Partial Overlap,Partial Overlap;Name=gssvL58685,gssvL58691,gssvL58684,gssvL58690,gssvL58698,gssvL58711,gssvL58687,gssvL58693,gssvL58719,gssvL58686,gssvL58699;Frequency=0.0288,0.0097,0.0139,0.0066,0.0107,0.0347,0.006,0.0085,0.03,0.0112,0.004;Type2=Loss,Loss,Loss,Loss,Loss,Loss,Loss,Loss,Loss,Loss,Loss;Region2=19:42786043-43283767,19:42804715-43042993,19:42814908-42983514,19:42864784-42911572,19:42908102-43039444,19:42953903-43038679,19:42973627-43023472;Span3=497725,238279,168607,46789,131343,84777,49846;OverlapType2=Within Region,Within Region,Partial Overlap,Contains Region,Partial Overlap,Partial Overlap,Contains Region;Type3=Deletion,Deletion,Deletion,Deletion,Deletion,Deletion,Deletion;Frequency2=0.00951374,0.025,0.0243129,0.000168947,0.0035503,0.00405474,0.0035503;DeletionFrequency=0.00951374,0.025,0.0243129,0.000168947,0.0035503,0.00405474,0.0035503;DuplicationFrequency=0,0,0,0,0,0,0;END=43026416	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:130.703:-2.57445:0.619641:1.85712709436754e-30:PSG1,PSG6,PSG7,PSG10P,PSG11::PSG1:NM_001184825.2:Benign:2F-1ThecnviscompletelycontainedinthehaplobenignregionISCA-37483inClinGenDosageSensitivity.,3A0Thiscnvoverlaps4proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:1
22	20717683	.	N	<DUP>	.	.	Type=Gain;Targets=2;Samples2=10;Span=1134;GeneNames=PI4KA;GeneIDs=5297;Aliases=GIDID2,PI4K-ALPHA,PIK4CA,PMGYCHA,SPG84,pi4K230;Genes=1;TranscriptNameClinicallyRelevant=NM_058004.4;OverlappingExonsClinicallyRelevant=44-45;HGVSg=NC_000022.11:g.20717683_20718816dup;HGVScClinicallyRelevant=NM_058004.4:c.5123_5317+25dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(22)q11.21;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=20718816	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:88.3542:3.36996:1.66732:0.00012688382541538:PI4KA::PI4KA:NM_058004.4:VUS:2B0WhiletheCNVoverlapsthePI4KAgeneitisunclearifthisisthecausativegeneforhaploinsufficientregionISCA-37446inClinGenDosageSensitivity.,2L0ThiscnvpartiallyoverlapsthePI4KAgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
